InMode Faces Multiple Unsolicited Acquisition Proposals
I'm LongbridgeAI, I can summarize articles.InMode confirmed receiving unsolicited acquisition proposals from Steel Partners and. Business Strategy, prompting its board to form a special committee for review. The company remains a strategic target in the medical tech sector. Analyst ratings are mixed, with TipRanks AI suggesting 'Outperform' due to strong financials, while average analyst sentiment is 'Hold'.
An update from InMode ( (INMD) ) is now available.
On July 10, 2026, InMode confirmed that its board received an unsolicited acquisition proposal from Steel Partners Holdings L.P., following a letter dated July 9, 2026. A special committee of independent directors, supported by legal and financial advisors, has been tasked with reviewing the offer in line with its fiduciary duties and is emphasizing its commitment to act in the best interests of all shareholders.
Separately, InMode’s board received a letter on July 8, 2026, from M.N. Business Strategy Ltd. extending the expiration date of its previously announced unsolicited proposal to September 15, 2026. The presence of multiple unsolicited approaches highlights InMode as a strategic target in the medical technology sector and could signal potential corporate change that investors and other stakeholders will closely monitor, even as the special committee declines further comment for now.
The most recent analyst rating on (INMD) stock is a Hold
with a $15.00 price target.
To see the full list of analyst forecasts on InMode stock,
see the INMD Stock Forecast page.
Spark’s Take on INMD Stock
According to Spark, TipRanks’ AI Analyst, INMD is a Outperform.
INMD scores well on financial strength and cash generation (high margins, strong FCF conversion, minimal debt), supported by an attractive low P/E. The score is held back by weaker technical momentum (negative MACD, below the 200-day) and earnings-call negatives around margin/opex pressure despite reiterated 2026 guidance and early signs of demand stabilization.
To see Spark’s full report on INMD stock,
click here.
More about InMode
InMode Ltd., based in Yokneam, Israel, is a global provider of innovative medical technologies focused on minimally invasive radiofrequency devices. Its systems enable new surgical procedures and enhance existing treatments across specialties including plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology, targeting clinicians seeking advanced RF-based therapeutic solutions.
The company develops, manufactures and markets its RF platforms worldwide, positioning itself in the fast-growing segment of aesthetic and surgical medical equipment. By offering a comprehensive product line tailored to multiple disciplines, InMode aims to consolidate its presence among healthcare providers looking for energy-based devices that support efficiency, patient outcomes and modern minimally invasive care.
Average Trading Volume: 833,235
Technical Sentiment Signal: Hold
Current Market Cap: $831.2M